Eye injection could stop retinal detachment from coming back
NCT ID NCT06425419
First seen Dec 10, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This early-stage study tests whether an injection of the drug topotecan into the eye can safely prevent retinal detachment from recurring in people with a condition called proliferative vitreoretinopathy (PVR). About 50 adults having surgery for retinal detachment will either receive the injection or standard care alone. Researchers will track safety and whether the retina stays attached for 6 months after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEGMATOGENOUS RETINAL DETACHMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.